The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags
21 minutes
Posted Aug 23, 2018 at 7:07 pm.
0:00
21:48
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens?
Previous
Episode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T
Next
Episode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer
← See all 425 episodes of The Readout Loud
